APA (7th ed.) Citation

Takemoto, S., Fukuda, M., Yamaguchi, H., Ikeda, T., Akagi, K., Tomono, H., . . . Mukae, H. (2020). Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study. Thoracic Cancer, 11(2), 389. https://doi.org/10.1111/1759-7714.13279

Chicago Style (17th ed.) Citation

Takemoto, Shinnosuke, et al. "Phase II Study of Ramucirumab and Docetaxel for Previously Treated Non‐small Cell Lung Cancer Patients with Malignant Pleural Effusion: Protocol of PLEURAM Study." Thoracic Cancer 11, no. 2 (2020): 389. https://doi.org/10.1111/1759-7714.13279.

MLA (9th ed.) Citation

Takemoto, Shinnosuke, et al. "Phase II Study of Ramucirumab and Docetaxel for Previously Treated Non‐small Cell Lung Cancer Patients with Malignant Pleural Effusion: Protocol of PLEURAM Study." Thoracic Cancer, vol. 11, no. 2, 2020, p. 389, https://doi.org/10.1111/1759-7714.13279.